%0 Journal Article
%@ 2369-2960
%I JMIR Publications
%V 3
%N 4
%P e85
%T HIV Surveillance Among Pregnant Women Attending Antenatal Clinics: Evolution and Current Direction
%A Dee,Jacob
%A Garcia Calleja,Jesus M
%A Marsh,Kimberly
%A Zaidi,Irum
%A Murrill,Christopher
%A Swaminathan,Mahesh
%+ Division of Global HIV and TB, US Centers for Disease Control and Prevention, 1600 Clifton Rd NE; MS E-30, Atlanta, GA, 30333, United States, 1 404 639 8409, idi0@cdc.gov
%K HIV
%K surveillance
%K prenatal
%K pregnant women
%K ethics
%D 2017
%7 05.12.2017
%9 Viewpoint
%J JMIR Public Health Surveill
%G English
%X Since the late 1980s, human immunodeficiency virus (HIV) sentinel serosurveillance among pregnant women attending select antenatal clinics (ANCs) based on unlinked anonymous testing (UAT) has provided invaluable information for tracking HIV prevalence and trends and informing global and national HIV models in most countries with generalized HIV epidemics. However, increased coverage of HIV testing, prevention of mother-to-child transmission (PMTCT), and antiretroviral therapy has heightened ethical concerns about UAT. PMTCT programs now routinely collect demographic and HIV testing information from the same pregnant women as serosurveillance and therefore present an alternative to UAT-based ANC serosurveillance. This paper reports on the evolution and current direction of the global approach to HIV surveillance among pregnant women attending ANCs, including the transition away from traditional UAT-based serosurveillance and toward new guidance from the World Health Organization and the Joint United Nations Programme on HIV/AIDS on the implementation of surveillance among pregnant women attending ANCs based on routine PMTCT program data.
%M 29208587
%R 10.2196/publichealth.8000
%U http://publichealth.jmir.org/2017/4/e85/
%U https://doi.org/10.2196/publichealth.8000
%U http://www.ncbi.nlm.nih.gov/pubmed/29208587